Biotech / Medtech Archives | citybizSciencenews

Biogen to Acquire Apellis for $5.6 Billion

Tuesday, March 31, 2026William HarrisView original

Biogen Inc. (Nasdaq: BIIB) and Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced the companies have entered into a definitive agreement under which Biogen... Read More

The post Biogen to Acquire Apellis for $5.6 Billion appeared first on citybiz.